Stable Q1 with 3.8% organic growth, strong U.S. and rest of world sales, and improved cash flow. Margins slightly down due to tariffs and FX, but EBIT margin up on lower restructuring costs. Strategy update expected H2 2026.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.